Biblio

Export 1233 results:
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
S. Dardenne, Delrieu, J., Sourdet, S., Cantet, C., Andrieu, S., Mathiex-Fortunet, H., Fougère, B., and Vellas, B., “Memory Complaints and Cognitive Decline: Data from the GUIDAGE Study1.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1567-1578, 2017.
S. Dardenne, Delrieu, J., Sourdet, S., Cantet, C., Andrieu, S., Mathiex-Fortunet, H., Fougère, B., and Vellas, B., “Memory Complaints and Cognitive Decline: Data from the GUIDAGE Study1.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1567-1578, 2017.
N. Gramunt, Sánchez-Benavides, G., Buschke, H., Diéguez-Vide, F., Peña-Casanova, J., Masramon, X., Fauria, K., Gispert, J. D., and Molinuevo, J. L., “The Memory Binding Test: Development of Two Alternate Forms into Spanish and Catalan.”, J Alzheimers Dis, vol. 52, no. 1, pp. 283-93, 2016.
E. van Duinkerken, Farme, J., Landeira-Fernandez, J., Dourado, M. C., Laks, J., and Mograbi, D. C., “Medical and Research Consent Decision-Making Capacity in Patients with Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 65, no. 3, pp. 917-930, 2018.
N. Nagaraja, Wang, W. - E., Duara, R., DeKosky, S. T., and Vaillancourt, D., “Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 93, no. 2, pp. 495-507, 2023.
N. Nagaraja, Wang, W. - E., Duara, R., DeKosky, S. T., and Vaillancourt, D., “Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 93, no. 2, pp. 495-507, 2023.
J. Alexander Jarholm, Bjørnerud, A., Dalaker, T. Olene, Akhavi, M. Sadat, Kirsebom, B. Eivind, Pålhaugen, L., Nordengen, K., Grøntvedt, G. Rolfseng, Nakling, A., Kalheim, L. F., Almdahl, I. S., Tecelao, S., Fladby, T., and Selnes, P., “Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.”, J Alzheimers Dis, vol. 94, no. 1, pp. 259-279, 2023.
O. M. Selivanova, Surin, A. K., Marchenkov, V. V., Dzhus, U. F., Grigorashvili, E. I., Suvorina, M. Yu, Glyakina, A. V., Dovidchenko, N. V., and Galzitskaya, O. V., “The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-β Peptide.”, J Alzheimers Dis, vol. 54, no. 2, pp. 821-30, 2016.
O. M. Selivanova, Surin, A. K., Marchenkov, V. V., Dzhus, U. F., Grigorashvili, E. I., Suvorina, M. Yu, Glyakina, A. V., Dovidchenko, N. V., and Galzitskaya, O. V., “The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-β Peptide.”, J Alzheimers Dis, vol. 54, no. 2, pp. 821-30, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P., “MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”, J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P., “MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”, J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P., “MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”, J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P., “MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”, J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
S. M. de la Monte, “Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).”, J Alzheimers Dis, vol. 95, no. 4, pp. 1301-1337, 2023.
M. Heffernan, Andrews, G., Singh, M. A. Fiataron, Valenzuela, M., Anstey, K. J., Maeder, A. J., McNeil, J., Jorm, L., Lautenschlager, N. T., Sachdev, P. S., Ginige, J. A., Hobbs, M. J., Boulamatsis, C., Chau, T., Cobiac, L., Cox, K. L., Daniel, K., Flood, V. M., Guerrero, Y., Gunn, J., Jain, N., Kochan, N. A., Lampit, A., Mavros, Y., Meiklejohn, J., Noble, Y., O'Leary, F., Radd-Vagenas, S., Walton, C. C., and Brodaty, H., “Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds.”, J Alzheimers Dis, vol. 70, no. s1, pp. S221-S237, 2019.
J. - C. Delgado-González, Florensa-Vila, J., Mansilla-Legorburo, F., Insausti, R., and Artacho-Pérula, E., “Magnetic Resonance Imaging and Anatomical Correlation of Human Temporal Lobe Landmarks, in 3D Euclidean Space: A Study of Control and Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 57, no. 2, pp. 461-473, 2017.
L
E. C. Pinnock, Jovanovic, K., Pinto, M. G., Ferreira, E., Dias, B. Da Costa, Penny, C., Knackmuss, S., Reusch, U., Little, M., Schatzl, H. M., and Weiss, S. F. T., “LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 645-57, 2016.
D. C. Hsu, Mormino, E. C., Schultz, A. P., Amariglio, R. E., Donovan, N. J., Rentz, D. M., Johnson, K. A., Sperling, R. A., and Marshall, G. A., “Lower Late-Life Body-Mass Index is Associated with Higher Cortical Amyloid Burden in Clinically Normal Elderly.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1097-105, 2016.
K. Ceyzériat, Tournier, B. B., Millet, P., Dipasquale, G., Koutsouvelis, N., Frisoni, G. B., Garibotto, V., and Zilli, T., “Low-Dose Radiation Therapy Reduces Amyloid Load in Young 3xTg-AD Mice.”, J Alzheimers Dis, vol. 86, no. 2, pp. 641-653, 2022.
J. - S. Vidal, Hanon, O., Funalot, B., Brunel, N., Viollet, C., Rigaud, A. - S., Seux, M. - L., le-Bouc, Y., Epelbaum, J., and Duron, E., “Low Serum Insulin-Like Growth Factor-I Predicts Cognitive Decline in Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 2, pp. 641-9, 2016.
Y. Chen, Sillaire, A. Rollin, Dallongeville, J., Skrobala, E., Wallon, D., Dubois, B., Hannequin, D., and Pasquier, F., “Low Prevalence and Clinical Effect of Vascular Risk Factors in Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1045-1054, 2017.
Y. Chen, Sillaire, A. Rollin, Dallongeville, J., Skrobala, E., Wallon, D., Dubois, B., Hannequin, D., and Pasquier, F., “Low Prevalence and Clinical Effect of Vascular Risk Factors in Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1045-1054, 2017.
D. Dingova, Fazekas, T., Okuliarova, P., Strbova, J., Kucera, M., and Hrabovska, A., “Low Plasma Cholinesterase Activities are Associated with Deficits in Spatial Orientation, Reduced Ability to Perform Basic Activities of Daily Living, and Low Body Mass Index in Patients with Progressed Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 3, pp. 801-13, 2016.
G. Palmieri, Cocca, E., Gogliettino, M., Valentino, R., Ruvo, M., Cristofano, G., Angiolillo, A., Balestrieri, M., Rossi, M., and Di Costanzo, A., “Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimer's Disease: A Sign of Defective Proteostasis?”, J Alzheimers Dis, vol. 60, no. 3, pp. 1097-1106, 2017.
F. Cacciamani, Tandetnik, C., Gagliardi, G., Bertin, H., Habert, M. - O., Hampel, H., Boukadida, L., Révillon, M., Epelbaum, S., and Dubois, B., “Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 2, pp. 753-762, 2017.

Pages